Vector Models and Indexing for Peptide Drug

Data Characteristics

Peptide drug pharmacovigilance data originates from clinical trial reports, real-world evidence (RWE) data, case reports, literature, and adverse event databases from global regulatory agencies such as the FDA Adverse Event Reporting System (FAERS) or EMA EudraVigilance. This data updates frequently, especially during post-market surveillance, with a continuous influx of new adverse reaction reports. Documents often contain unstructured free-text descriptions (e.g., adverse event details, patient history, medication use) and semi-structured fields (e.g., drug name, dosage, batch number, report date, patient age, gender, adverse reaction terminology codes like MedDRA codes). Peptide drugs are unique due to their structural complexity, immunogenicity, and potential for specific mechanism-related adverse reactions. These characteristics often appear in text descriptions with specialized terminology and biological mechanism details.

Constraints Imposed by These Characteristics on Vector Models and Indexing

The high update frequency of peptide drug pharmacovigilance data requires vector indexes to support efficient incremental updates, avoiding frequent full rebuilds. The mix of unstructured free text and specialized terminology demands higher semantic understanding from vector models. Specifically, models must accurately capture adverse reaction context, drug-reaction associations, and descriptions of peptide drug-specific biological effects. The presence of semi-structured fields suggests integrating structured information during vectorization to improve retrieval precision. For example, similarity-based retrieval alone might not differentiate the same adverse reaction at different dosages or batch numbers. Additionally, data may contain numerous medical abbreviations, synonyms, and inconsistent expressions. This requires vector models to be robust enough to handle noise and map to the correct conceptual space.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`embeddingModel`	`text-embedding-3-large`	Improves understanding of medical terminology and complex semantics, especially for peptide drug-specific biological descriptions.
`chunkSize`	`500–800 characters`	Balances contextual completeness and vectorization efficiency, preventing excessive truncation of key information.
`overlapSize`	`100–150 characters`	Ensures contextual continuity, reducing the risk of information loss at chunk boundaries.
`Recall count`	`10–15 entries`	Increases recall diversity, covering more potentially relevant pharmacovigilance information.
`Similarity threshold`	`Calibrate by actual measurement`	Requires iterative optimization on test sets based on actual retrieval performance and false positive rates.
`Rerank result count`	`Top 5 entries`	Focuses on the most relevant results, balancing accuracy with user reading burden.

Three Common Pitfalls

Retrieval results do not reflect the latest information after knowledge base updates: This occurs when the incremental indexing mechanism is not triggered correctly, or the cache is not refreshed promptly.
Retrieval results contain a large amount of irrelevant or generalized information: This happens due to an unreasonable chunking strategy, where individual chunks lack sufficient context to convey complete semantics, or the vector model fails to accurately distinguish peptide drug-specific adverse reaction descriptions.
Significant performance degradation or errors after changing embeddingModel: This is because the knowledge base index was not rebuilt after the model change. This leads to incompatibility between vectors generated by the old model and the new model, resulting in errors like undefined model must match.

How to Verify Proper Configuration

Perform retrievals on a typical query set. Observe if the recalled results include expected key adverse event reports and peptide drug-specific information. Compare these results with human evaluations.
Monitor incremental update logs for the knowledge base. Confirm that the index updates promptly as expected after new data ingestion, without significant delays.
Construct queries containing peptide drug-specific professional terms and abbreviations. Validate the accuracy and relevance of retrieval results to ensure the vector model correctly handles these specialized terms.
Check system logs to confirm embeddingModel calls are error-free and show no model mismatch or timeout error messages.

Note: The values provided are common starting points. They should be measured against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.